Literature DB >> 16456532

CD8+ T cells are effector cells of contact dermatitis to common skin allergens in mice.

Marc Vocanson1, Anca Hennino, Magalie Cluzel-Tailhardat, Pierre Saint-Mezard, Josette Benetiere, Cyril Chavagnac, Frederic Berard, Dominique Kaiserlian, Jean-François Nicolas.   

Abstract

Allergic contact dermatitis (ACD) to strong experimental haptens is mediated by specific CD8+ T cells. Here, we show that similar mechanisms occur for weak haptens, which comprise the vast majority of chemicals responsible for human ACD. We used a model of ACD, that is, the contact hypersensitivity reaction, to test for the allergenicity of three weak haptens involved in fragrance allergy. ACD to weak haptens could not be induced in normal mice. In contrast, mice acutely depleted in CD4+ T cells developed a typical ACD reaction to the three weak fragrance allergens that peaked 24 hours after challenge. Priming of CD8+ T cells was observed in draining lymph nodes 5 days after sensitization and development of ACD was associated with the infiltration of activated CD8+ T cells in the challenged skin. CD8+ T cells were effectors of the ACD reaction as in vivo treatment with depleting anti-CD8 mAbs abrogated the ACD responses and as purified CD8+ T cells could adoptively transfer ACD to naive recipients. In conclusion, our data demonstrate a dominant role of CD8+ T cells as initiators of ACD to weak haptens, and suggest that CD8+ T cells may represent potential targets for preventing or treating ACD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16456532     DOI: 10.1038/sj.jid.5700174

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  23 in total

Review 1.  T-cell recognition of chemicals, protein allergens and drugs: towards the development of in vitro assays.

Authors:  Stefan F Martin; Philipp R Esser; Sonja Schmucker; Lisa Dietz; Dean J Naisbitt; B Kevin Park; Marc Vocanson; Jean-Francois Nicolas; Monika Keller; Werner J Pichler; Matthias Peiser; Andreas Luch; Reinhard Wanner; Enrico Maggi; Andrea Cavani; Thomas Rustemeyer; Anne Richter; Hermann-Josef Thierse; Federica Sallusto
Journal:  Cell Mol Life Sci       Date:  2010-08-18       Impact factor: 9.261

2.  Targeting effector memory T cells with the small molecule Kv1.3 blocker PAP-1 suppresses allergic contact dermatitis.

Authors:  Philippe Azam; Ananthakrishnan Sankaranarayanan; Daniel Homerick; Stephen Griffey; Heike Wulff
Journal:  J Invest Dermatol       Date:  2007-02-01       Impact factor: 8.551

Review 3.  Dendritic cells and contact dermatitis.

Authors:  Yoshinori Sasaki; Setsuya Aiba
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

4.  Combination of oxymatrine and diammonium glycyrrhizinate significantly mitigates mice allergic contact dermatitis induced by dinitrofluorobenzene.

Authors:  Hui-Juan Shi; Hong-Bin Song; Qiong Gao; Jia-Wei Si; Qian Zou
Journal:  Exp Biol Med (Maywood)       Date:  2019-07-25

5.  An essential role for TAK1 in the contact hypersensitivity response.

Authors:  Yan G Zhao; Yunqi Wang; Weidong Hao; Yisong Y Wan
Journal:  Cell Mol Immunol       Date:  2011-05-09       Impact factor: 11.530

Review 6.  The Unique Molecular Signatures of Contact Dermatitis and Implications for Treatment.

Authors:  Alexandra Leonard; Emma Guttman-Yassky
Journal:  Clin Rev Allergy Immunol       Date:  2019-02       Impact factor: 8.667

7.  Prevention of diabetes in NOD mice by repeated exposures to a contact allergen inducing a sub-clinical dermatitis.

Authors:  Kaare Engkilde; Karsten Buschard; Axel Kornerup Hansen; Torkil Menné; Jeanne Duus Johansen
Journal:  PLoS One       Date:  2010-05-11       Impact factor: 3.240

8.  CD8 T cells regulate allergic contact dermatitis by modulating CCR2-dependent TNF/iNOS-expressing Ly6C+ CD11b+ monocytic cells.

Authors:  Shu Zhen Chong; Kar Wai Tan; Fiona H S Wong; Yen Leong Chua; Yafang Tang; Lai Guan Ng; Veronique Angeli; David M Kemeny
Journal:  J Invest Dermatol       Date:  2013-09-23       Impact factor: 8.551

9.  Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity.

Authors:  Krzysztof Bryniarski; Wlodzimierz Ptak; Asha Jayakumar; Kerstin Püllmann; Michael J Caplan; Arthit Chairoungdua; Jun Lu; Brian D Adams; Emilia Sikora; Katarzyna Nazimek; Susanna Marquez; Steven H Kleinstein; Panjamaporn Sangwung; Yasuko Iwakiri; Eric Delgato; Frank Redegeld; Bart R Blokhuis; Jacek Wojcikowski; Anna Wladyslawa Daniel; Tom Groot Kormelink; Philip W Askenase
Journal:  J Allergy Clin Immunol       Date:  2013-05-31       Impact factor: 10.793

10.  Oral probiotic control skin inflammation by acting on both effector and regulatory T cells.

Authors:  Feriel Hacini-Rachinel; Hanane Gheit; Jean-Benoit Le Luduec; Fariel Dif; Stéphane Nancey; Dominique Kaiserlian
Journal:  PLoS One       Date:  2009-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.